Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

BACKGROUND AND AIMS: Patients with intermediate-stage hepatocellular carcinoma (HCC) refractory to transcatheter arterial chemoembolization (TACE) are considered to be candidates for sorafenib. The aim of this study was to evaluate the superiority of conversion of treatment to sorafenib on overall s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Cancer
Main Authors: Arizumi, Tadaaki, Ueshima, Kazuomi, Minami, Tomohiro, Kono, Masashi, Chishina, Hirokazu, Takita, Masahiro, Kitai, Satoshi, Inoue, Tatsuo, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2015
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698649/
https://ncbi.nlm.nih.gov/pubmed/26734579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000367743
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados